GlassScriptPhysician profile
Manuel Skow
NPI 1083888481
$12,509.77
in general payments reported to CMS, 2019-2025
59 companies · $2,551 in 2025
The $2,551 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,462 · 2022: $2,654 · 2023: $2,535 · 2024: $2,308 · 2025: $2,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,393.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,157.95 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,002.05 | 2021-2025 | |
| Lilly USA, LLC | $913.41 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $766.55 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Merck Sharp & Dohme LLC | $731.70 | 2021-2025 | Verquvo, Gardasil 9, Capvaxive |
| Pfizer INC. | $691.36 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $572.72 | 2021-2025 | Jardiance |
| Amgen INC. | $523.26 | 2021-2025 | Evenity, Prolia, Krystexxa |
| Janssen Pharmaceuticals, INC | $361.70 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $345.39 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $316.70 | 2021-2025 | Xifaxan, Trulance |
| Optinose US, INC. | $301.36 | 2021-2024 | |
| Dexcom, INC. | $299.57 | 2021-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Daiichi Sankyo INC. | $285.15 | 2021-2023 | Injectafer |
| Glaxosmithkline, LLC. | $251.94 | 2021-2024 | Shingrix, Arexvy, Trelegy Ellipta |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $222.36 | 2021-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $218.09 | 2022 | |
| Sanofi-Aventis U.S. LLC | $215.87 | 2021-2023 | |
| Astellas Pharma US INC | $204.98 | 2021-2025 | Veozah |
| Lundbeck LLC | $175.01 | 2021-2025 | Vyepti, Rexulti |
| Exact Sciences Corporation | $144.72 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Gilead Sciences, INC. | $127.37 | 2023-2025 | |
| Amarin Pharma, INC. | $115.75 | 2021-2023 | |
| Axsome Therapeutics, INC. | $107.07 | 2023-2025 | Auvelity, Sunosi |
| Organon LLC | $92.87 | 2022-2025 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $88.30 | 2021-2022 | |
| Medtronic, INC. | $83.49 | 2021-2024 | Closurefast |
| Eisai INC. | $80.07 | 2021 | |
| Dynavax Technologies Corporation | $78.14 | 2021-2024 | Heplisav-B |
| Otsuka America Pharmaceutical, INC. | $78.11 | 2022-2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $75.92 | 2023 | Quviviq |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $75.79 | 2025 | Caplyta |
| Alexion Pharmaceuticals, INC. | $66.03 | 2022 | |
| Vanda Pharmaceuticals INC. | $65.89 | 2024-2025 | Hetlioz, Fanapt |
| Jazz Pharmaceuticals INC. | $56.29 | 2021-2022 | |
| Corcept Therapeutics | $54.08 | 2024-2025 | Korlym |
| Biohaven Pharmaceuticals, INC. | $49.99 | 2021 | |
| Xeris Pharmaceuticals, INC. | $46.43 | 2021-2025 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $35.52 | 2023-2024 | |
| Azurity Pharmaceuticals, INC. | $31.62 | 2023 | Horizant |
| Seqirus USA INC | $28.96 | 2024 | Flucelvax, Fluad |
| Therapeuticsmd, INC. | $28.93 | 2021 | |
| Globus Medical, INC. | $27.84 | 2025 | Senza |
| Currax Pharmaceuticals LLC | $26.45 | 2021-2023 | Onzetra Xsail, Contrave |
| Radius Health, INC. | $24.46 | 2025 | |
| Arbor Pharmaceuticals, INC. | $24.21 | 2021 | |
| Biogen, INC. | $22.76 | 2022 | |
| Alfasigma USA, INC. | $22.73 | 2022 | |
| Neos Therapeutics, LP | $22.13 | 2023 | Adzenys Xr-Odt |
| Bausch Health US, LLC | $20.87 | 2025 | Wellbutrin |
| Ultragenyx Pharmaceutical INC. | $20.87 | 2021 | |
| Horizon Therapeutics Plc | $19.66 | 2023 | Krystexxa |
| Corium, LLC | $19.63 | 2023 | Azstarys |
| Nevro Corp. | $18.43 | 2023 | Senza |
| Tactile Systems Technology INC | $14.92 | 2023 | Flexitouch Plus, Entre Plus |
| Paratek Pharmaceuticals, INC. | $14.91 | 2021 | |
| Insulet Corporation | $14.66 | 2025 | Omnipod |
| Ironwood Pharmaceuticals, INC | $13.66 | 2021 | |
| Mannkind Corporation | $13.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Skow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.